BIDIL Drug Patent Profile
✉ Email this page to a colleague
When do Bidil patents expire, and when can generic versions of Bidil launch?
Bidil is a drug marketed by Azurity and is included in one NDA.
The generic ingredient in BIDIL is hydralazine hydrochloride; isosorbide dinitrate. There are twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydralazine hydrochloride; isosorbide dinitrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BIDIL?
- What are the global sales for BIDIL?
- What is Average Wholesale Price for BIDIL?
Summary for BIDIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Patent Applications: | 6 |
Drug Prices: | Drug price information for BIDIL |
What excipients (inactive ingredients) are in BIDIL? | BIDIL excipients list |
DailyMed Link: | BIDIL at DailyMed |
Pharmacology for BIDIL
Drug Class | Arteriolar Vasodilator Nitrate Vasodilator |
Physiological Effect | Arteriolar Vasodilation Vasodilation |
US Patents and Regulatory Information for BIDIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Azurity | BIDIL | hydralazine hydrochloride; isosorbide dinitrate | TABLET;ORAL | 020727-001 | Jun 23, 2005 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BIDIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Azurity | BIDIL | hydralazine hydrochloride; isosorbide dinitrate | TABLET;ORAL | 020727-001 | Jun 23, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Azurity | BIDIL | hydralazine hydrochloride; isosorbide dinitrate | TABLET;ORAL | 020727-001 | Jun 23, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Azurity | BIDIL | hydralazine hydrochloride; isosorbide dinitrate | TABLET;ORAL | 020727-001 | Jun 23, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BIDIL
See the table below for patents covering BIDIL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2383974 | ⤷ Sign Up | |
European Patent Office | 1212053 | ⤷ Sign Up | |
Australia | 7365900 | ⤷ Sign Up | |
World Intellectual Property Organization (WIPO) | 0117528 | ⤷ Sign Up | |
Canada | 1308659 | METHODE DE REDUCTION DE LA MORTALITE ASSOCIEE A L'INSUFFISANCE CARDIAQUE CONGESTIVE FAISANT APPEL A L'HYDRALAZINE ET AU DINITRATE D'ISOSOBIDE (METHOD OF REDUCING MORTALITY ASSOCIATED WITH CONGESTIVE HEART FAILURE USING HYDRALAZINE AND ISOSORBIDE DINITRATE) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |